# Guardian Pharmacy Services, Inc.: filings

GRDN · NYSE · CIK 1802255 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/grdn.md) · [Financials](/companies/grdn/financials.md) · [Filings](/companies/grdn/filings.md) · [Insiders](/companies/grdn/insiders.md)

## Reports and events: 43 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 82, 8-K 24, 3 19, SCHEDULE 13G/A 16, SC 13G 7, UPLOAD 7, 10-Q 6, DRS/A 6, SCHEDULE 13G 6, CORRESP 5, DRSLTR 5, SCHEDULE 13D/A 4, 10-K 2, 424B4 2, 424B5 2, DEF 14A 2, DEFA14A 2, DRS 2, EFFECT 2, S-1 2, S-1/A 2, S-8 2, 424A 1, 424B3 1, 8-A12B 1, CERT 1, S-1MEF 1, S-3 1, S-3ASR 1, S-3MEF 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 17:02 ET | [SCHEDULE 13D/A](/filings/0001193125-26-405492.md) | Ownership report, active investor, amended | 0001193125-26-405492 |
| 2026-09-10 | 16:05 ET | [8-K](/filings/0001193125-26-387858.md) | 8.01 Other events | 0001193125-26-387858 |
| 2026-08-06 | 16:17 ET | [10-Q](/filings/0001193125-26-338074.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338074 |
| 2026-08-06 | 16:12 ET | [8-K](/filings/0001193125-26-338032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338032 |
| 2026-06-22 | 16:35 ET | [8-K](/filings/0001193125-26-277596.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-277596 |
| 2026-05-28 | 16:11 ET | [8-K](/filings/0001193125-26-245235.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-245235 |
| 2026-05-07 | 16:12 ET | [8-K](/filings/0001193125-26-211924.md) | 5.07 Shareholder vote results | 0001193125-26-211924 |
| 2026-05-06 | 16:16 ET | [10-Q](/filings/0001193125-26-209021.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209021 |
| 2026-05-06 | 16:13 ET | [8-K](/filings/0001193125-26-208989.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208989 |
| 2026-03-26 | 07:18 ET | [DEF 14A](/filings/0001193125-26-125070.md) | Proxy statement, period 2026-05-05 | 0001193125-26-125070 |
| 2026-03-24 | 18:17 ET | [SCHEDULE 13D/A](/filings/0001193125-26-122330.md) | Ownership report, active investor, amended | 0001193125-26-122330 |
| 2026-03-23 | 16:19 ET | [8-K](/filings/0001193125-26-119772.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-119772 |
| 2026-03-11 | 16:15 ET | [10-K](/filings/0001193125-26-102172.md) | Annual report, period 2025-12-31 | 0001193125-26-102172 |
| 2026-03-11 | 16:11 ET | [8-K](/filings/0001193125-26-102153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-102153 |
| 2026-01-13 | 16:41 ET | [8-K](/filings/0001193125-26-011826.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-011826 |
| 2025-11-10 | 16:17 ET | [10-Q](/filings/0001193125-25-274298.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274298 |
| 2025-11-10 | 16:10 ET | [8-K](/filings/0001193125-25-274250.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274250 |
| 2025-10-14 | 16:51 ET | [8-K](/filings/0001193125-25-239120.md) | 8.01 Other events | 0001193125-25-239120 |
| 2025-09-18 | 06:30 ET | [8-K](/filings/0001193125-25-206771.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-206771 |
| 2025-08-11 | 16:26 ET | [10-Q](/filings/0001193125-25-177969.md) | Quarterly report, period 2025-06-30 | 0001193125-25-177969 |
| 2025-08-11 | 16:23 ET | [8-K](/filings/0001193125-25-177963.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-177963 |
| 2025-07-29 | 16:54 ET | [SCHEDULE 13D/A](/filings/0000950170-25-099705.md) | Ownership report, active investor, amended | 0000950170-25-099705 |
| 2025-06-18 | 09:15 ET | [8-K](/filings/0001193125-25-142451.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-142451 |
| 2025-05-29 | 16:05 ET | [SCHEDULE 13D/A](/filings/0000950170-25-078935.md) | Ownership report, active investor, amended | 0000950170-25-078935 |
| 2025-05-20 | 16:09 ET | [S-1](/filings/0001193125-25-123149.md) | Registration statement | 0001193125-25-123149 |
| 2025-05-20 | 16:06 ET | [8-K](/filings/0001193125-25-123145.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-123145 |
| 2025-05-12 | 16:25 ET | [8-K](/filings/0001193125-25-117815.md) | 5.07 Shareholder vote results | 0001193125-25-117815 |
| 2025-05-12 | 16:20 ET | [10-Q](/filings/0001193125-25-117801.md) | Quarterly report, period 2025-03-31 | 0001193125-25-117801 |
| 2025-05-12 | 16:16 ET | [8-K](/filings/0001193125-25-117795.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-117795 |
| 2025-03-28 | 16:01 ET | [8-K](/filings/0001193125-25-067044.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-067044 |
| 2025-03-28 | 07:20 ET | [DEF 14A](/filings/0001193125-25-066235.md) | Proxy statement, period 2025-05-09 | 0001193125-25-066235 |
| 2025-03-26 | 16:15 ET | [10-K](/filings/0001193125-25-064082.md) | Annual report, period 2024-12-31 | 0001193125-25-064082 |
| 2025-03-26 | 16:12 ET | [8-K](/filings/0001193125-25-064079.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-064079 |
| 2025-03-03 | 06:16 ET | [8-K](/filings/0001193125-25-043339.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-043339 |
| 2025-02-11 | 16:30 ET | [8-K](/filings/0001193125-25-024341.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-024341 |
| 2025-02-03 | 17:00 ET | [SCHEDULE 13D](/filings/0000950170-25-012420.md) | Ownership report, active investor | 0000950170-25-012420 |
| 2024-12-20 | 16:06 ET | [8-K](/filings/0001193125-24-283106.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-283106 |
| 2024-11-12 | 17:00 ET | [10-Q](/filings/0001193125-24-256069.md) | Quarterly report, period 2024-09-30 | 0001193125-24-256069 |
| 2024-11-12 | 16:19 ET | [8-K](/filings/0001193125-24-255981.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255981 |
| 2024-09-30 | 16:05 ET | [8-K](/filings/0001193125-24-228997.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-228997 |
| 2024-09-16 | 08:22 ET | [S-1/A](/filings/0001193125-24-219239.md) | Registration statement, amended | 0001193125-24-219239 |
| 2024-08-22 | 17:17 ET | [S-1/A](/filings/0001193125-24-205420.md) | Registration statement, amended | 0001193125-24-205420 |
| 2023-10-03 | 17:03 ET | [S-1](/filings/0001193125-23-250013.md) | Registration statement | 0001193125-23-250013 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.